GH

Georgianna Harris

Merck: 11 patents #1,033 of 9,382Top 15%
ME Merial: 1 patents #200 of 414Top 50%
📍 Tinton Falls, NJ: #25 of 215 inventorsTop 15%
🗺 New Jersey: #7,307 of 69,400 inventorsTop 15%
Overall (All Time): #424,529 of 4,157,543Top 15%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
7718390 Toxoplasma gondii cylclic GMP dependent protein kinase G as a chemotherapeutic target for antiprotozoal agents Anne Gurnett, Robert G. K. Donald, Paul Liberator, Dennis M. Schmatz, Sandra J. Rattray 2010-05-18
7125700 Cyclic GMP dependent protein kinase as a chemotherapeutic target for antiprotozoal agents Anne Gurnett, Robert G. K. Donald, Paul Liberator, Dennis M. Schmatz, Sandra J. Rattray 2006-10-24
6555358 Polynucleotide encoding eimeria tenella cGMP dependent protein kinase Anne Gurnett, Paul Liberator, Robert G. K. Donald, Dennis M. Schmatz, Sandra J. Rattray 2003-04-29
6352997 Method of improving in-vitro fertilization Joanne Waldstreicher 2002-03-05
5962442 Irreversible inhibition of human 5.alpha.-reductase Herb G. Bull 1999-10-05
5935968 Methods for treating polycystic ovary syndrome Joanne Waldstreicher 1999-08-10
5932559 Treatment of hyperandrogenic conditions Herb G. Bull, Robert W. Myers 1999-08-03
5763361 17-alkyl-7-substituted-4-aza steroid derivatives as 5-.alpha.-reductase inhibitors Richard L. Tolman, Soumya P. Sahoo 1998-06-09
5756480 Treatment of hyperandrogenic conditions Herb G. Bull, Robert W. Myers 1998-05-26
5710275 7.beta.-substituted-4-aza-5.alpha.-androstan-3-ones as 5.alpha.-reductase inhibitors Raman K. Bakshi, Gary H. Rasmusson, Richard L. Tolman, Gool F. Patel, Donald W. Graham +1 more 1998-01-20
5656613 Treatment of hyperandrogenic conditions Herb G. Bull 1997-08-12
5527807 7.beta.-substituted-4-aza-5.alpha.-cholestan-3-ones as 5.alpha. reductase inhibitors useful in the prevention and treatment of hyperandrogenetic disorders Raman K. Bakshi, Gary H. Rasmusson, Richard L. Tolman, Gool F. Patel 1996-06-18